Another关键词检索结果

持久能力:JPEO-CBRND 通过国家复原力发展公私伙伴关系

Enduring Capability: JPEO-CBRND evolves public/private partnership with National Resilience

在 COVID-19 大流行之前,还发生过其他较小规模的疫情,例如 SARS 以及 2000 年代初的 H1N1 大流行流感恐慌,引发了公共卫生方法的变化。其中一项变革是在佛罗里达州阿拉楚阿建立国防部先进开发和制造 (DoD-ADM) 设施。 2009 年 H1N1 流感传播后,美国国防高级研究计划局 (DARPA) 资助对美国政府的生物医学对策 (MCM) 响应能力进行了评估,发现快速开发、许可和制造保护所需的生物 MCM 的需求尚未得到满足CBRN 危机期间的军事和平民人口,其中包括自然发生的流行病以及蓄意攻击。根据这份报告,总统国土安全和反恐助理约翰·O·布伦南 (John O. Bre

AI 根据大脑活动记录重新创建平克·弗洛伊德 (Pink Floyd) 曲目

ИИ воссоздает трек Pink Floyd по записям активности головного мозга

加州大学伯克利分校的研究人员在患者聆听 Pink Floyd 的歌曲“Another Brick in the Wall, Part 1”时记录了大脑区域的电活动。使用人工智能,他们能够根据大脑的颅内脑电图记录重建这首歌。

每周回顾 2024 年 6 月 14 日

Weekly Review 14 June 2024

我上周在 Twitter 上发布的一些有趣链接(我也在 Mastodon、Threads、Newsmast 和 Bluesky 上发布了这些链接):欧洲也正在进入 AI 战斗机/僚机领域:https://www.theregister.com/2024/06/05/airbus_wingman_drone/仅仅因为它包含 AI,并不意味着它真的有用:https://www.theverge.com/2024/6/6/24172718/humane-ai-pin-selling-hp-rumor-1-billion生物大脑比计算机节能得多。而且它们并不比今天的人工智能更不可靠:https://w

Yandex推出全新YATI技术并升级Yandex.Station

Яндекс представил новую технология YATI и прокаченную Яндекс.Станцию

新产品作为 YaC 2020 的一部分进行展示。通常 Yet Another Conference 包括舞台表演和场外现场交流,但今年的形式发生了变化。该公司没有举办传统的会议,而是准备了一部电影。

迈向大麻研究的又一步

Another step towards marijuana research

I covered the ridiculous barriers to researching marijuana over at Healthcare Triage: But now the feds have taken another step towards making this better: The Obama administration is planning to remove a major roadblock to marijuana research, officials said Wednesday, potentially spurring broad scie

为什么阿片类药物替代疗法不仅取代了另一种成瘾

Why opioid substitution therapy is not just replacing one addiction for another

The following is the text of my email to Peter Friedmann, Brown University Professor of Medicine and Professor of Health Services, Policy & Practice and an expert on substance use and addiction medicine: In response to my NYT piece on treatment for opioid dependence, I received email with a question

图表:按年龄按健康支出

Chart: Health spending by age

Here’s another chart from the JAMA study “The Anatomy of Health Care in the United States“: From it, we can compute average health spending by age, in 2004. I’ve shown that below alongside an estimate of what that spending is today, assuming 2.5% growth per year since 2004, which seems at least roug

记录(每日回顾)

On The Record (with daily recap)

Kaiser: Drew Altman looks at what’s in store during 2012 Today in TIE: Don wonders who owns the MMSE and points out some good resources that can help you think about causation, while Aaron has two posts on paying for things that work: one focused on the macro level, and another on the doctor/patient

记录(每日回顾)

On The Record (with daily recap)

GAO: Health Oppty Accounts Demonstration in Medicaid BPC: Domenici-Rivlin Proect Medicare Act Brookings: Controlling Medicare Costs: Is Premium Support the Answer?(video archive soon) Today in TIE: Reflex, Fifth installment of Austin’s series on premium support in Medicare, and he shows that Med Adv

记录(每日回顾)

On The Record (with daily recap)

Today in TIE: Reflex, Austin takes another look at Romney’s reform ideas, and reviews the inconsistent way we worry about exchanges depending upon the age of the patients involved, Don wants to get the language straight on palliative care, and discusses the first lawsuit for not following a POLST fo

Pharma的研究

Pharma’s Research

Kevin Drum has a piece up discussing Megan McArdle citing Derick Rowe: Via Megan McArdle, Derek Lowe blogs today about an entire field of pharmaceutical research revolving around PPAR ligands that pretty much went nowhere and cost drug companies a bundle: Allow me to rant for a bit, because I saw ye